Equities

Diamond Biofund Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6901:TAI

Diamond Biofund Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (TWD)16.05
  • Today's Change-0.05 / -0.31%
  • Shares traded513.06k
  • 1 Year change-51.07%
  • Beta1.2939
Data delayed at least 20 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.

  • Revenue in TWD (TTM)-1.70bn
  • Net income in TWD-1.93bn
  • Incorporated2013
  • Employees33.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Capital Futures Corp2.94bn1.20bn13.07bn--10.281.3110.194.455.095.0912.5540.070.0447--35.06--1.821.6813.5912.3356.5857.9140.7132.78----0.004573.4419.296.6117.8914.70-1.758.58
Diamond Biofund Inc-1.70bn-1.93bn13.69bn33.00--1.48-----2.26-2.26-1.9910.83-0.1639-----51,436,000.00-18.609.09-18.769.21------78.15----0.01072.748.64--2.53--58.37--
China Bills Finance Corp2.74bn1.70bn23.17bn161.0013.660.853213.478.451.261.262.0420.220.0107--278.2416,423,850.000.66410.64776.025.42----61.8763.49----0.893371.1111.362.066.662.0014.361.61
President Securities Corp11.36bn3.43bn47.24bn1.86k14.011.2912.334.162.112.116.9122.920.0553--0.3656,457,314.001.682.569.4410.1191.8191.2730.3631.26--14.660.638657.3436.0712.7251.9013.0517.785.12
Data as of Feb 11 2026. Currency figures normalised to Diamond Biofund Inc's reporting currency: Taiwan Dollar TWD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.